|
US3091570A
(en)
|
1960-08-08 |
1963-05-28 |
Lakeside Lab Inc |
Antidepressant: 3-pyrrolidyl glycolates
|
|
GB1219606A
(en)
*
|
1968-07-15 |
1971-01-20 |
Rech S Et D Applic Scient Soge |
Quinuclidinol derivatives and preparation thereof
|
|
FR2414044A1
(fr)
|
1978-01-10 |
1979-08-03 |
Pharmindustrie |
Nouveaux derives d'aza-1 bicyclo(2,2,2) octane, utilisables comme medicaments
|
|
IT7920688U1
(it)
|
1979-02-05 |
1980-08-05 |
Chiesi Paolo |
Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore
|
|
DE3274065D1
(de)
|
1981-07-08 |
1986-12-11 |
Draco Ab |
Powder inhalator
|
|
FR2539135B1
(fr)
*
|
1983-01-11 |
1986-02-28 |
Essilor Int |
Hydrogels de polyurethane et procede de fabrication
|
|
US4570630A
(en)
|
1983-08-03 |
1986-02-18 |
Miles Laboratories, Inc. |
Medicament inhalation device
|
|
GB8334494D0
(en)
*
|
1983-12-24 |
1984-02-01 |
Tanabe Seiyaku Co |
Carbostyril derivatives
|
|
GB8613811D0
(en)
|
1986-06-06 |
1986-07-09 |
Phares Pharm Res Nv |
Composition & method
|
|
FI69963C
(fi)
|
1984-10-04 |
1986-09-12 |
Orion Yhtymae Oy |
Doseringsanordning
|
|
US4675326A
(en)
*
|
1985-05-08 |
1987-06-23 |
Gabriel Amitai |
Bisquaternary antidotes
|
|
US4855290A
(en)
|
1985-05-10 |
1989-08-08 |
State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research |
Derivatives of quinuclidine
|
|
US4843074A
(en)
*
|
1988-05-17 |
1989-06-27 |
Marion Laboratories, Inc. |
1-azabicyclo[2.2.2]octan-3-yl 2-aryl-3-azacyclo-2-hydroxypropionates and their quaternary salts
|
|
DE3927170A1
(de)
|
1989-08-17 |
1991-02-21 |
Boehringer Ingelheim Kg |
Inhalator
|
|
US5290815A
(en)
|
1989-09-07 |
1994-03-01 |
Glaxo Group Limited |
Treatment of inflammation and allergy
|
|
US5610163A
(en)
*
|
1989-09-16 |
1997-03-11 |
Boehringer Ingelheim Gmbh |
Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
|
|
DE3931041C2
(de)
|
1989-09-16 |
2000-04-06 |
Boehringer Ingelheim Kg |
Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
|
|
GB8923590D0
(en)
|
1989-10-19 |
1989-12-06 |
Pfizer Ltd |
Antimuscarinic bronchodilators
|
|
IT1237118B
(it)
|
1989-10-27 |
1993-05-18 |
Miat Spa |
Inalatore multidose per farmaci in polvere.
|
|
US5201308A
(en)
|
1990-02-14 |
1993-04-13 |
Newhouse Michael T |
Powder inhaler
|
|
GB9004781D0
(en)
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
|
SG45171A1
(en)
|
1990-03-21 |
1998-01-16 |
Boehringer Ingelheim Int |
Atomising devices and methods
|
|
GB9015522D0
(en)
|
1990-07-13 |
1990-08-29 |
Braithwaite Philip W |
Inhaler
|
|
WO1992003175A1
(en)
|
1990-08-11 |
1992-03-05 |
Fisons Plc |
Inhalation device
|
|
DE4027391A1
(de)
|
1990-08-30 |
1992-03-12 |
Boehringer Ingelheim Kg |
Treibgasfreies inhalationsgeraet
|
|
US5507281A
(en)
|
1990-08-30 |
1996-04-16 |
Boehringer Ingelheim Kg |
Device for initiating a mechanical switching operation in synchronism with the breathing
|
|
DE69132735T2
(de)
|
1990-09-06 |
2002-05-29 |
Pfizer Inc., New York |
Anti-muscarin bronchodilatoren
|
|
US5091528A
(en)
|
1990-09-12 |
1992-02-25 |
Allergan, Inc. |
6- or 7- (2-imino-2-imidazolidine)-1,4-benzoxazines as α adrenergic agents
|
|
ATE209938T1
(de)
|
1990-09-26 |
2001-12-15 |
Pharmachemie Bv |
Wirbelkammer-pulverinhalator
|
|
GB9026025D0
(en)
|
1990-11-29 |
1991-01-16 |
Boehringer Ingelheim Kg |
Inhalation device
|
|
US5290539A
(en)
|
1990-12-21 |
1994-03-01 |
Minnesota Mining And Manufacturing Company |
Device for delivering an aerosol
|
|
EP0504112A3
(en)
|
1991-03-14 |
1993-04-21 |
Ciba-Geigy Ag |
Pharmaceutical aerosol formulations
|
|
DE4108393A1
(de)
*
|
1991-03-15 |
1992-09-17 |
Boehringer Ingelheim Kg |
Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
|
|
AU650953B2
(en)
|
1991-03-21 |
1994-07-07 |
Novartis Ag |
Inhaler
|
|
US6299863B1
(en)
|
1992-04-03 |
2001-10-09 |
Sepracor Inc. |
Aerosol formulations containing micronized optically pure (R,R) formoterol for bronchodilating therapy
|
|
GB9119705D0
(en)
|
1991-09-14 |
1991-10-30 |
Pfizer Ltd |
Therapeutic compounds
|
|
DE4239402A1
(de)
*
|
1992-11-24 |
1994-05-26 |
Bayer Ag |
Pulverinhalator
|
|
WO1994013263A1
(en)
|
1992-12-09 |
1994-06-23 |
Jager Paul D |
Stabilized medicinal aerosol solution formulations
|
|
UA27961C2
(uk)
|
1992-12-18 |
2000-10-16 |
Шерінг Корпорейшн |
Інгалятор для порошкових ліків
|
|
EP0747355A4
(en)
|
1994-02-10 |
1997-04-09 |
Yamanouchi Pharma Co Ltd |
NEW CARBAMATES AND MEDICINAL PRODUCTS CONTAINING THEM
|
|
GB9404945D0
(en)
|
1994-03-15 |
1994-04-27 |
Glaxo Group Ltd |
Pharmaceutical composition
|
|
US5569447A
(en)
|
1994-04-19 |
1996-10-29 |
The United States Of America Represented By The Secretary Department Of Health And Human Services |
Stannylated 3-quinuclidinyl benzilates and methods of preparing radiohalogenated derivatives
|
|
JP3548933B2
(ja)
|
1994-07-29 |
2004-08-04 |
ミネソタ マイニング アンド マニュファクチャリング カンパニー |
架橋結合された粘弾性高分子材料に硬化可能なアクリル系シロップ
|
|
GB9426252D0
(en)
|
1994-12-24 |
1995-02-22 |
Glaxo Group Ltd |
Pharmaceutical composition
|
|
NO2005012I1
(no)
|
1994-12-28 |
2005-06-06 |
Debio Rech Pharma Sa |
Triptorelin og farmasoytisk akseptable salter derav
|
|
US5585115A
(en)
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
|
GB9501841D0
(en)
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
|
EP1908488A3
(en)
|
1995-04-14 |
2008-04-16 |
SmithKline Beecham Corporation |
Metered dose inhaler for salmeterol
|
|
AU719449B2
(en)
*
|
1995-06-21 |
2000-05-11 |
Astrazeneca Ab |
Pharmaceutical powder cartridge with integrated metering device and inhaler for powdered medicaments
|
|
DE19528145A1
(de)
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
|
DE19536902A1
(de)
|
1995-10-04 |
1997-04-10 |
Boehringer Ingelheim Int |
Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
|
|
US5846983A
(en)
|
1996-02-09 |
1998-12-08 |
Mayo Foundation For Medical Education And Research |
Colonic delivery of nicotine to treat inflammatory bowel disease
|
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
|
US5885834A
(en)
|
1996-09-30 |
1999-03-23 |
Epstein; Paul M. |
Antisense oligodeoxynucleotide against phosphodiesterase
|
|
FR2756739B1
(fr)
*
|
1996-12-05 |
2000-04-28 |
Astra Ab |
Nouvelle formulation de budesonide
|
|
US6495167B2
(en)
|
1997-03-20 |
2002-12-17 |
Schering Corporation |
Preparation of powder agglomerates
|
|
GB9807232D0
(en)
|
1998-04-03 |
1998-06-03 |
Univ Cardiff |
Aerosol composition
|
|
DE19826118C2
(de)
|
1998-06-12 |
2003-09-18 |
Beiersdorf Ag |
Wasserhaltige kosmetische oder pharmazeutische Stifte
|
|
EP1087750B1
(en)
|
1998-06-18 |
2003-11-12 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Pharmaceutical formulations for aerosols with two or more active substances
|
|
US6423298B2
(en)
|
1998-06-18 |
2002-07-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Pharmaceutical formulations for aerosols with two or more active substances
|
|
ITMI981671A1
(it)
|
1998-07-21 |
2000-01-21 |
Zambon Spa |
Derivati ftalazinici inibitori della fosfodisterasi 4
|
|
EP1102579B1
(de)
*
|
1998-08-04 |
2003-03-19 |
Jago Research Ag |
Medizinische aerosolformulierungen
|
|
US5962505A
(en)
|
1998-08-31 |
1999-10-05 |
Bobrove; Arthur M. |
Method for treating hot flashes in humans
|
|
DE19847968A1
(de)
|
1998-10-17 |
2000-04-20 |
Boehringer Ingelheim Pharma |
Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
|
|
GB9902689D0
(en)
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
|
DE19921693A1
(de)
*
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
|
US20040002548A1
(en)
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
US7214687B2
(en)
*
|
1999-07-14 |
2007-05-08 |
Almirall Ag |
Quinuclidine derivatives and medicinal compositions containing the same
|
|
ES2165768B1
(es)
*
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
SE9902935D0
(sv)
|
1999-08-18 |
1999-08-18 |
Astra Pharma Prod |
Pharmaceutical compositions
|
|
GB9928311D0
(en)
|
1999-11-30 |
2000-01-26 |
Novartis Ag |
Organic compounds
|
|
US6410563B1
(en)
|
1999-12-22 |
2002-06-25 |
Merck Frosst Canada & Co. |
Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
|
|
FR2803378B1
(fr)
|
1999-12-29 |
2004-03-19 |
Valeo Climatisation |
Echangeur de chaleur a tubes a plusieurs canaux, en particulier pour vehicule automobile
|
|
CA2398199A1
(en)
|
2000-01-28 |
2001-08-02 |
Asahi Kasei Kabushiki Kaisha |
Novel therapeutic agents that use a .beta.3 agonist
|
|
WO2001057025A1
(en)
|
2000-01-31 |
2001-08-09 |
Pfizer Products Inc. |
Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
|
|
CA2404226A1
(en)
|
2000-03-23 |
2001-09-27 |
Takeda Chemical Industries, Ltd. |
Furoisoquinoline derivatives, process for producing the same and use thereof
|
|
GB0008485D0
(en)
|
2000-04-07 |
2000-05-24 |
Glaxo Group Ltd |
Pharmaceutical compositions
|
|
GB0009606D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Therapeutic combinations
|
|
GB0009592D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory combinations
|
|
GB0009605D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Medicaments
|
|
GB0009583D0
(en)
|
2000-04-18 |
2000-06-07 |
Glaxo Group Ltd |
Respiratory formulations
|
|
GB0012261D0
(en)
|
2000-05-19 |
2000-07-12 |
Astrazeneca Ab |
Novel process
|
|
BR0015884A
(pt)
|
2000-05-22 |
2003-07-08 |
Chiesi Farma Spa |
Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados
|
|
US20020052312A1
(en)
|
2000-05-30 |
2002-05-02 |
Reiss Theodore F. |
Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists
|
|
AR029984A1
(es)
|
2000-07-27 |
2003-07-23 |
Smithkline Beecham Corp |
Metodo para reducir las exacerbaciones asociadas copd ambito
|
|
US6852728B2
(en)
|
2000-10-14 |
2005-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Anticholinergics, processes for preparing them, and pharmaceutical compositions containing them
|
|
US6706726B2
(en)
|
2000-10-14 |
2004-03-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Anticholinergics which may be used as medicaments as well as processes for preparing them
|
|
US20020151541A1
(en)
*
|
2000-10-31 |
2002-10-17 |
Michel Pairet |
Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
|
|
US20020193393A1
(en)
*
|
2001-03-07 |
2002-12-19 |
Michel Pairet |
Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
|
|
DE10110772A1
(de)
|
2001-03-07 |
2002-09-12 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren
|
|
US20030158196A1
(en)
*
|
2002-02-16 |
2003-08-21 |
Boehringer Ingelheim Pharma Gmbh Co. Kg |
Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
|
|
US6608054B2
(en)
*
|
2001-03-20 |
2003-08-19 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics and endothelin antagonists
|
|
DE10062712A1
(de)
*
|
2000-12-15 |
2002-06-20 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
|
|
US20020122773A1
(en)
*
|
2000-12-20 |
2002-09-05 |
Michel Pairet |
Pharmaceutical compositions based on anticholinergics and dopamine agonists
|
|
AU2002210575A1
(en)
*
|
2000-10-31 |
2002-05-15 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Novel medicament compositions based on anticholinergics and corticosteroids
|
|
US6620438B2
(en)
*
|
2001-03-08 |
2003-09-16 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
|
|
US20020137764A1
(en)
*
|
2000-10-31 |
2002-09-26 |
Karin Drechsel |
Inhalable formulation of a solution containing a tiotropium salt
|
|
US7776315B2
(en)
*
|
2000-10-31 |
2010-08-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and additional active ingredients
|
|
US20020183292A1
(en)
*
|
2000-10-31 |
2002-12-05 |
Michel Pairet |
Pharmaceutical compositions based on anticholinergics and corticosteroids
|
|
US20020193392A1
(en)
*
|
2000-11-13 |
2002-12-19 |
Christel Schmelzer |
Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
|
|
DE10056104A1
(de)
|
2000-11-13 |
2002-05-23 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
|
|
US20100310477A1
(en)
*
|
2000-11-28 |
2010-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Pharmaceutical compositions based on anticholingerics and additional active ingredients
|
|
KR100869722B1
(ko)
|
2000-12-22 |
2008-11-21 |
알미랄 에이쥐 |
퀴누클리딘 카르바메이트 유도체 및 ｍ3 길항제로서 그의사용
|
|
NZ526674A
(en)
*
|
2000-12-28 |
2005-03-24 |
Almirall Prodesfarma Ag |
Novel quinuclidine derivatives and medicinal compositions containing the same
|
|
DE10104370A1
(de)
|
2001-02-01 |
2002-08-08 |
Boehringer Ingelheim Pharma |
Arzneimittelkompositionen mit geringeren Nebenwirkungen
|
|
DE10104367A1
(de)
|
2001-02-01 |
2002-08-08 |
Boehringer Ingelheim Pharma |
Betamimetika enthaltende Arzneimittelkompositionen mit geringeren Nebenwirkungen
|
|
US20020179087A1
(en)
*
|
2001-02-01 |
2002-12-05 |
Karl-Heinz Bozung |
Pharmaceutical compositions containing an oxitropium salt and a betamimetic
|
|
US20020189610A1
(en)
*
|
2001-02-01 |
2002-12-19 |
Karl-Heinz Bozung |
Pharmaceutical compositions containing an ipratropium salt and a betamimetic
|
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
|
US20030216329A1
(en)
|
2001-04-24 |
2003-11-20 |
Robinson Cynthia B. |
Composition, formulations & kit for treatment of respiratory & lung disease with dehydroepiandrosterone(s) steroid & an anti-muscarinic agent(s)
|
|
MXPA03010791A
(es)
|
2001-05-25 |
2004-03-02 |
Boehringer Ingelheim Pharma |
Combinacion de inhibidor de pde4 y tiotropio a sus derivados para tratamiento de enfermedades obstructivas de vias respiratorias y de otras enfermedades inflamatorias.
|
|
CZ20033150A3
(cs)
|
2001-05-25 |
2004-06-16 |
Pfizer Inc. |
Inhibitor PDE4 a anticholinergní činidlo v kombinaci pro léčbu obstruktivních chorob dýchacích cest
|
|
GB0115181D0
(en)
|
2001-06-20 |
2001-08-15 |
Glaxo Group Ltd |
Novel use
|
|
DE10129703A1
(de)
*
|
2001-06-22 |
2003-01-02 |
Sofotec Gmbh & Co Kg |
Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
|
|
DE10130371A1
(de)
*
|
2001-06-23 |
2003-01-02 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
|
|
US20030018019A1
(en)
*
|
2001-06-23 |
2003-01-23 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
|
|
GB0118373D0
(en)
|
2001-07-27 |
2001-09-19 |
Glaxo Group Ltd |
Novel therapeutic method
|
|
US6919325B2
(en)
|
2001-09-14 |
2005-07-19 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
|
|
US6680345B2
(en)
|
2001-09-14 |
2004-01-20 |
Boehringer Ingelheim Pharma Kg |
Salicylic acid salts of salmeterol
|
|
CA2459493C
(en)
|
2001-09-14 |
2011-08-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New pharmaceutical compositions for inhalation
|
|
WO2003042160A1
(en)
|
2001-11-13 |
2003-05-22 |
Theravance, Inc. |
Aryl aniline beta-2 adrenergic receptor agonists
|
|
US6974803B2
(en)
|
2001-12-06 |
2005-12-13 |
Pfizer Inc |
Pharmaceutical combination
|
|
DE10202940A1
(de)
|
2002-01-24 |
2003-07-31 |
Sofotec Gmbh & Co Kg |
Patrone für einen Pulverinhalator
|
|
US6790856B2
(en)
|
2002-01-31 |
2004-09-14 |
Boehringer Ingelheim Pharma Kg |
Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
|
|
GB0202635D0
(en)
|
2002-02-05 |
2002-03-20 |
Glaxo Wellcome Mfg Pte Ltd |
Formulation containing novel anti-inflammatory androstane derivative
|
|
KR100947409B1
(ko)
|
2002-03-01 |
2010-03-12 |
키에시 파르마슈티시 엣스. 피. 에이. |
포모테롤 초미세 조성물
|
|
US6756508B2
(en)
|
2002-03-04 |
2004-06-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Cinnamic acid salts, processes for their preparation, and their use as medicaments
|
|
DE10216429A1
(de)
|
2002-04-12 |
2003-10-23 |
Boehringer Ingelheim Pharma |
Arzneimittel enthaltend Steroide und ein neues Anticholinergikum
|
|
DE10216333A1
(de)
|
2002-04-13 |
2003-10-30 |
Boehringer Ingelheim Pharma |
Neue Carbonsäureester mit anticholonerger Wirksamkeit, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
|
|
US7094788B2
(en)
|
2002-04-13 |
2006-08-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Esters of hydroxyl-substituted nitrogen heterocycles, processes for the preparation thereof as well as the use thereof as pharmaceutical compositions
|
|
ES2206021B1
(es)
*
|
2002-04-16 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de pirrolidinio.
|
|
ES2195785B1
(es)
|
2002-05-16 |
2005-03-16 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
ES2204295B1
(es)
|
2002-07-02 |
2005-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de quinuclidina-amida.
|
|
US20040058950A1
(en)
|
2002-07-09 |
2004-03-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
|
|
GB0230045D0
(en)
*
|
2002-12-23 |
2003-01-29 |
Glaxo Group Ltd |
Compounds
|
|
ES2211315B1
(es)
|
2002-11-12 |
2005-10-16 |
Almirall Prodesfarma, S.A. |
Nuevos compuestos triciclicos.
|
|
AU2003289898A1
(en)
|
2002-11-27 |
2004-06-18 |
Altana Pharma Ag |
Pde4 and pde3/4 inhibitors for use in the treatment of cachexia
|
|
ES2211344B1
(es)
|
2002-12-26 |
2005-10-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
|
DE10307759B3
(de)
|
2003-02-19 |
2004-11-18 |
Schering Ag |
Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel
|
|
EP1452179A1
(en)
|
2003-02-27 |
2004-09-01 |
CHIESI FARMACEUTICI S.p.A. |
Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid
|
|
US20040184995A1
(en)
|
2003-03-17 |
2004-09-23 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel dry powder inhalation for lung-delivery and manufacturing method thereof
|
|
SI1610787T1
(sl)
|
2003-03-28 |
2008-06-30 |
Nycomed Gmbh |
Sinergistična kombinacija, ki obsega roflumilastin antiholinergično sredstvo, izbrano izmed tiotropijevih soli, za zdravljenje respiratornih bolezni
|
|
US20060189642A1
(en)
|
2003-03-28 |
2006-08-24 |
Altana Pharma Ag |
Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
|
|
US20050026887A1
(en)
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a steroid
|
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
|
PT1651270E
(pt)
*
|
2003-07-29 |
2007-04-30 |
Boehringer Ingelheim Int |
Medicamentos para inalação compreendendo betamiméticos e um anticolinérgico
|
|
RU2361586C2
(ru)
*
|
2003-07-29 |
2009-07-20 |
Берингер Ингельхайм Интернациональ Гмбх |
Комбинация из антихолинергического средства и стероида и ее применение для лечения заболеваний дыхательных путей путем ингаляции
|
|
CA2534125A1
(en)
|
2003-07-29 |
2005-02-17 |
Boehringer Ingelheim International Gmbh |
Medicaments comprising pde iv inhibitors and an anticholinergic for treating respiratory disorders
|
|
US20050026886A1
(en)
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a PDE IV inhibitor
|
|
US20050025718A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
|
CA2534120C
(en)
*
|
2003-07-31 |
2012-09-11 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising anticholinergics and a betamimetic
|
|
DE10347994A1
(de)
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
|
ES2232306B1
(es)
|
2003-11-10 |
2006-08-01 |
Almirall Prodesfarma, S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
PT1713473E
(pt)
|
2004-02-06 |
2013-05-13 |
Meda Pharma Gmbh & Co Kg |
Combinação de anticolinérgicos e glucocorticóides para o tratamento a longo prazo de asma e copd
|
|
DE602005007708D1
(de)
|
2004-02-06 |
2008-08-07 |
Meda Pharma Gmbh & Co Kg |
Neue kombination von anticholinergen und beta mimetika zur behanldung von atemwegserkrankungen
|
|
WO2005074982A2
(en)
|
2004-02-06 |
2005-08-18 |
Meda Pharma Gmbh & Co. Kg |
Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
|
|
ES2239546B1
(es)
|
2004-03-15 |
2006-12-01 |
Almirall Prodesfarma, S.A. |
Nuevos esteres de quinuclidina cuaternizados.
|
|
DE102004016179A1
(de)
|
2004-03-30 |
2005-10-20 |
Boehringer Ingelheim Pharma |
Verbindungen zur Behandlung von proliferativen Prozessen
|
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
SI1765404T1
(sl)
|
2004-05-31 |
2009-04-30 |
Almirall Lab |
Kombinacije, ki obsegajo antimuskarinska sredstva in beta-adrenergične agoniste
|
|
ES2251866B1
(es)
|
2004-06-18 |
2007-06-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
ES2251867B1
(es)
|
2004-06-21 |
2007-06-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de piridazin-3(2h)-ona.
|
|
EP2484382A1
(en)
|
2005-03-30 |
2012-08-08 |
Schering Corporation |
Medicament comprising a phosphodiesterase IV inhibitor in an inhalable form
|
|
ES2298049B1
(es)
*
|
2006-07-21 |
2009-10-20 |
Laboratorios Almirall S.A. |
Procedimiento para fabricar bromuro de 3(r)-(2-hidroxi-2,2-ditien-2-ilacetoxi)-1-(3-fenoxipropil)-1-azoniabiciclo (2.2.2) octano.
|
|
GB0702457D0
(en)
|
2007-02-08 |
2007-03-21 |
Astrazeneca Ab |
New combination 666
|
|
JP2010519195A
(ja)
|
2007-02-19 |
2010-06-03 |
シプラ・リミテッド |
薬学的組成物
|
|
KR20090114401A
(ko)
|
2007-02-21 |
2009-11-03 |
알미랄 에스.에이. |
신규 방법
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100599A1
(en)
*
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
DE102008061575B4
(de)
|
2008-12-11 |
2010-11-25 |
Continental Automotive Gmbh |
Wellrohr einer Kraftstoffleitung
|
|
US20100023433A1
(en)
*
|
2009-07-24 |
2010-01-28 |
Hombek Ryszard |
Apparatus and method for tax collection
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
EP2666465A1
(en)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Novel dosage and formulation
|